Age ≥ 65 years, CK ≥ 180 U/L, and CD4+ T-cell counts <300 cells/μL at admission were risk factors independently associated with disease progression to severe COVID-19 during 14 days after admission and are therefore potential markers for disease progression in patients with milder COVID-19. The gene discussed is CD4; the disease is COVID-19.